Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Newspaper Article
|
Tiny Lab Sees Profit Potential in SARS TestThe Wall Street journal. Eastern edition, 2003-06-10Copyright Dow Jones & Company Inc Jun 10, 2003 ;ISSN: 0099-9660 ;EISSN: 2574-9579Digital Resources/Online E-Resources |
|
2 |
Material Type: Newspaper Article
|
Interferons May Be First to Reach Trials for SARSThe Wall Street journal. Eastern edition, 2003-09-16Copyright (c) 2003, Dow Jones & Company, Inc. ;ISSN: 0099-9660 ;EISSN: 2574-9579Digital Resources/Online E-Resources |
|
3 |
Material Type: Newspaper Article
|
Search Continues for SARS Drugs; Compounds Are Studied In the Test Tube for Now; Stricter Human Tests LoomThe Wall Street journal. Eastern edition, 2003-09-17Copyright (c) 2003, Dow Jones & Company, Inc. ;ISSN: 0099-9660 ;EISSN: 2574-9579Digital Resources/Online E-Resources |
|
4 |
Material Type: Newspaper Article
|
Progress Reported in SARS Vaccine EffortThe New York times, 2003-11-09Copyright New York Times Company Nov 9, 2003 ;ISSN: 0362-4331 ;CODEN: NYTIAODigital Resources/Online E-Resources |
|
5 |
Material Type: Newspaper Article
|
Progress Reported in SARS Vaccine EffortNew York Times (Online), 2003-11-09Copyright 2019 The New York Times Company ;EISSN: 1553-8095Full text available |
|
6 |
Material Type: Newsletter Article
|
Jiji Press Roundup of Recent Bio News 1Jiji Press English News Service, 2003, p.1Copyright JIJI Press America, Ltd. Jul 25, 2003 ;Copyright JIJI Press America, Ltd. Oct 3, 2003 ;Copyright JIJI Press America, Ltd. Jul 1, 2003 ;Copyright JIJI Press America, Ltd. Dec 1, 2003 ;Copyright JIJI Press America, Ltd. Sep 8, 2003 ;Copyright JIJI Press America, Ltd. May 19, 2003 ;Copyright JIJI Press America, Ltd. Feb 17, 2003 ;Copyright JIJI Press America, Ltd. May 13, 2003 ;Copyright JIJI Press America, Ltd. May 6, 2003 ;Copyright JIJI Press America, Ltd. Sep 22, 2003 ;Copyright JIJI Press America, Ltd. Dec 12, 2003 ;Copyright JIJI Press America, Ltd. Dec 25, 2003 ;Copyright JIJI Press America, Ltd. Nov 20, 2003 ;Copyright JIJI Press America, Ltd. Oct 28, 2003 ;Copyright JIJI Press America, Ltd. Aug 20, 2003 ;Copyright JIJI Press America, Ltd. Aug 12, 2003 ;Copyright JIJI Press America, Ltd. Aug 5, 2003 ;Copyright JIJI Press America, Ltd. Jul 9, 2003 ;Copyright JIJI Press America, Ltd. Jun 19, 2003 ;Copyright JIJI Press America, Ltd. Jun 11, 2003 ;Copyright JIJI Press America, Ltd. May 27, 2003 ;Copyright JIJI Press America, Ltd. Apr 28, 2003 ;Copyright JIJI Press America, Ltd. Apr 21, 2003 ;Copyright JIJI Press America, Ltd. Mar 4, 2003 ;Copyright JIJI Press America, Ltd. Aug 28, 2003 ;Copyright JIJI Press America, Ltd. Apr 14, 2003 ;Copyright JIJI Press America, Ltd. Feb 25, 2003 ;Copyright JIJI Press America, Ltd. Mar 10, 2003 ;Copyright JIJI Press America, Ltd. Jun 4, 2003 ;Copyright JIJI Press America, Ltd. Jul 17, 2003Digital Resources/Online E-Resources |
|
7 |
Material Type: Article
|
Treatment and vaccines for severe acute respiratory syndromeThe Lancet infectious diseases, 2005-03, Vol.5 (3), p.147-155 [Peer Reviewed Journal]2005 Elsevier Ltd ;2005 INIST-CNRS ;Copyright Elsevier Limited Mar 2005 ;Copyright © 2005 Elsevier Ltd. All rights reserved. 2005 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(05)01307-1 ;PMID: 15766649 ;CODEN: LANCAOFull text available |
|
8 |
Material Type: Newsletter Article
|
JIJI PRESS ROUNDUP OF RECENT BIO NEWS 1Jiji Press English News Service, 2005, p.1Copyright JIJI Press America, Ltd. Jul 1, 2005 ;Copyright JIJI Press America, Ltd. Jun 16, 2005 ;Copyright JIJI Press America, Ltd. Apr 21, 2005 ;Copyright JIJI Press America, Ltd. Dec 30, 2005 ;Copyright JIJI Press America, Ltd. Mar 25, 2005 ;Copyright JIJI Press America, Ltd. Jan 12, 2005 ;Copyright JIJI Press America, Ltd. Dec 16, 2005 ;Copyright JIJI Press America, Ltd. Sep 17, 2005 ;Copyright JIJI Press America, Ltd. Apr 8, 2005 ;Copyright JIJI Press America, Ltd. Oct 7, 2005 ;Copyright JIJI Press America, Ltd. Mar 9, 2005 ;Copyright JIJI Press America, Ltd. May 18, 2005 ;Copyright JIJI Press America, Ltd. Jun 1, 2005 ;Copyright JIJI Press America, Ltd. Aug 8, 2005 ;Copyright JIJI Press America, Ltd. Aug 30, 2005 ;Copyright JIJI Press America, Ltd. Nov 25, 2005 ;Copyright JIJI Press America, Ltd. Oct 28, 2005 ;Copyright JIJI Press America, Ltd. Jan 26, 2005 ;Copyright JIJI Press America, Ltd. Jul 19, 2005Digital Resources/Online E-Resources |
|
9 |
Material Type: Article
|
Structure and inhibition of the SARS coronavirus envelope protein ion channelPLoS pathogens, 2009-07, Vol.5 (7), p.e1000511-e1000511 [Peer Reviewed Journal]COPYRIGHT 2009 Public Library of Science ;Pervushin et al. 2009 ;2009 Pervushin et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Pervushin K, Tan E, Parthasarathy K, Lin X, Jiang FL, et al. (2009) Structure and Inhibition of the SARS Coronavirus Envelope Protein Ion Channel. PLoS Pathog 5(7): e1000511. doi:10.1371/journal.ppat.1000511 ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/journal.ppat.1000511 ;PMID: 19593379Full text available |
|
10 |
Material Type: Newsletter Article
|
Drug combo helps reduce MERS disease in animal study; possible human optionThe Canadian Press, 20132013 The Canadian Press. All rights reserved.Digital Resources/Online E-Resources |
|
11 |
Material Type: Article
|
Clinical epidemiology of bocavirus, rhinovirus, two polyomaviruses and four coronaviruses in HIV-infected and HIV-uninfected South African childrenPloS one, 2014-02, Vol.9 (2), p.e86448-e86448 [Peer Reviewed Journal]COPYRIGHT 2014 Public Library of Science ;COPYRIGHT 2014 Public Library of Science ;2014 Nunes et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2014 Nunes et al 2014 Nunes et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0086448 ;PMID: 24498274Full text available |
|
12 |
Material Type: Newsletter Article
|
BioCryst Announces Nature Publication Demonstrating Efficacy of BCX4430 in a Non-Human Primate Model of Filovirus Infection: Broad Spectrum Activity Shown Against Multiple RNA Virus BiothreatsNASDAQ OMX's News Release Distribution Channel, 2014Copyright NASDAQ OMX Corporate Solutions, Inc. Mar 3, 2014Digital Resources/Online E-Resources |
|
13 |
Material Type: Newsletter Article
|
Press Release: BioCryst Announces Nature Publication Demonstrating Efficacy of BCX4430 in a Non-Human Primate Model of Filovirus InfectionDow Jones Institutional News, 2014Copyright Dow Jones & Company Inc Mar 3, 2014Digital Resources/Online E-Resources |
|
14 |
Material Type: Article
|
Recent Advances in Dipeptidyl-Peptidase-4 Inhibition Therapy: Lessons from the Bench and Clinical TrialsJournal of diabetes research, 2015-01, Vol.2015, p.606031-14 [Peer Reviewed Journal]Copyright © 2015 Jixin Zhong et al. ;Copyright © 2015 Jixin Zhong et al. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright © 2015 Jixin Zhong et al. 2015 ;ISSN: 2314-6745 ;EISSN: 2314-6753 ;DOI: 10.1155/2015/606031 ;PMID: 26075284Full text available |
|
15 |
Material Type: Newsletter Article
|
Mundipharma Presents Research on Efficacy of BETADINE(R) Formulations Against MERS at Inaugural International Meeting on Respiratory Pathogens (IMRP)PR Newswire Asia, 2015Copyright © 2015 PR Newswire Association LLC. All Rights Reserved.Digital Resources/Online E-Resources |
|
16 |
Material Type: Newsletter Article
|
Experts at World Congress of Internal Medicines Reinforce Importance of BETADINE(R) in Disease Prevention, Infection Control and Oral Mucositis Treatment: New in-vitro studies demonstrate BETADINE® medicines containing Povidone-Iodine (PVP-I) have a rapid virucidal kill rate against MERS coronavirusPR Newswire Asia, 2016Copyright © 2016 PR Newswire Association LLC. All Rights Reserved.Digital Resources/Online E-Resources |
|
17 |
Material Type: Article
|
Offering patients more: how the West Africa Ebola outbreak can shape innovation in therapeutic research for emerging and epidemic infectionsPhilosophical transactions of the Royal Society of London. Series B. Biological sciences, 2017-05, Vol.372 (1721), p.20160294-20160294 [Peer Reviewed Journal]2017 The Authors. ;Copyright The Royal Society Publishing May 26, 2017 ;2017 The Authors. 2017 ;ISSN: 0962-8436 ;EISSN: 1471-2970 ;DOI: 10.1098/rstb.2016.0294 ;PMID: 28396467Full text available |
|
18 |
Material Type: Article
|
ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in miceVaccine, 2017-06, Vol.35 (30), p.3780-3788 [Peer Reviewed Journal]2017 The Authors ;Copyright © 2017. Published by Elsevier Ltd. ;Copyright Elsevier Limited Jun 27, 2017 ;2017 The Authors 2017 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2017.05.032 ;PMID: 28579232Full text available |
|
19 |
Material Type: Article
|
Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technologyVaccine, 2017-08, Vol.35 (35), p.4461-4464 [Peer Reviewed Journal]The Authors ;2017 The Authors ;Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved. ;Copyright Elsevier Limited Aug 16, 2017 ;2017 The Authors 2017 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2017.04.085 ;PMID: 28576573Full text available |
|
20 |
Material Type: Newsletter Article
|
MERS Antibodies Produced in Cattle Safe, Treatment Well Tolerated in Phase 1 TrialTargeted News Service, 2018Copyright © Targeted News Service. All Rights Reserved.Digital Resources/Online E-Resources |